Sudhir Manne - Krebs Biochemicals Head Nellore

All Insiders . India . 
Stock . Krebs Biochemicals and . Stakeholders . Insider . Sudhir Manne
KREBSBIO   82.30  0.03  0.04%   

Executive

Sudhir Manne is Head Nellore of Krebs Biochemicals and
Address Kothapalli Village, Visakhapatnam, India, 531031
Phone91 91 2114 4984
Webhttps://krebsbiochem.com

Krebs Biochemicals Management Efficiency

The company has return on total asset (ROA) of (0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals' Total Current Assets are decreasing as compared to previous years. The Krebs Biochemicals' current Intangible Assets is estimated to increase to about 27.7 M, while Total Assets are projected to decrease to under 1.3 B.
Krebs Biochemicals and has accumulated 2.39 B in total debt. Debt can assist Krebs Biochemicals until it has trouble settling it off, either with new capital or with free cash flow. So, Krebs Biochemicals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Krebs Biochemicals and sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Krebs to invest in growth at high rates of return. When we think about Krebs Biochemicals' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Sundar RamanReliance Industries Limited
N/A
Mukund PendseReliance Industries Limited
N/A
Jayati DMDState Bank of
59
Harish ShahReliance Industries Limited
N/A
Pradeep PandeyLife Insurance
51
Anindya BanerjeeICICI Bank Limited
48
Parimal NathwaniReliance Industries Limited
N/A
Sudhir JhaHDFC Bank Limited
57
Parag RaoHDFC Bank Limited
58
Nirav ShahHDFC Bank Limited
50
Vivek RanjanICICI Bank Limited
N/A
SudhakarLife Insurance
N/A
Hemen ModiReliance Industries Limited
N/A
Saloni NarayanState Bank of
N/A
Ratnakar PatnaikLife Insurance
N/A
Pandiyan KumaresanLife Insurance
N/A
Anshul SinghLife Insurance
N/A
Rana SinghState Bank of
N/A
Kameshwar KodavantiState Bank of
N/A
Pawan AgrawalLife Insurance
N/A
Laxminarayan AcharICICI Bank Limited
N/A
Krebs Biochemicals and (KREBSBIO) is traded on National Stock Exchange of India in India and employs 191 people. Krebs Biochemicals is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Return On Asset-0.0532

Krebs Biochemicals and Leadership Team

Elected by the shareholders, the Krebs Biochemicals' board of directors comprises two types of representatives: Krebs Biochemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Krebs. The board's role is to monitor Krebs Biochemicals' management team and ensure that shareholders' interests are well served. Krebs Biochemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Krebs Biochemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Rakesh Kalbate, Company Officer
Aditya Ravi, Head Vizag
Sudhir Manne, Head Nellore
Keyur Doshi, Company Officer
Ritesh Jain, Chief Officer
Ravi Babu, Chief Officer
Jitendra Shah, CEO MD
Pabitra Bhattacharya, MD Director

Krebs Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Krebs Biochemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-0.0532
Profit Margin(0.37) %
Operating Margin(0.30) %
Current Valuation3.73 B
Shares Outstanding21.56 M
Shares Owned By Insiders77.55 %
Price To Sales3.37 X
Revenue504.21 M
Gross Profit244.19 M
EBITDA(82.73 M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Krebs Stock

Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY